Japanese Researchers Warn About Using Blood Transfusions From COVID-19 mRNA Jab Recipients

Image source: https://thevaccinereaction.org/2024/03/red-cross-does-not-sort-blood-donors-by-covid-vaccination-status/

To this day, the American Red Cross wants blood donors to know that—despite all the confirmed devastating side effects and deaths—receiving an mRNA COVID-19 jab does not make you ineligible to donate blood. Okey-Dokey fact-checker verified, their website declares, “True: you can donate blood after getting a COVID-19 vaccine.” Besides that, the Red Cross insists, “Blood donations from those who have been vaccinated for COVID-19 are safe for transfusion,” noting on its website that “like all blood collectors in the U.S., [the Red Cross] is required to follow the eligibility guidelines set by the Food and Drug Administration (FDA).” That sounds comforting, except trusting the FDA related to anything to do with the gene-damaging COVID shots has revealed a misinformation propaganda campaign with the agency’s hocus-pocus on full display. Thankfully, researchers in Japan are very concerned about the risks associated with blood transfusions from individuals who have received mRNA COVID-19 jabs. In a March 14, 2024, preprint, the authors warn:

“The impact of these genetic vaccines on blood products and the actual damage caused by them are unknown at present. Therefore, in order to avoid these risks and prevent further expansion of blood contamination and complication of the situation, we strongly request that the vaccination campaign using genetic vaccines be suspended and that a harm–benefit assessment be carried out as early as possible.   

As we have repeatedly stated, the health injuries caused by genetic vaccination are already extremely serious, and it is high time that countries and relevant organizations take concrete steps together to identify the risks and to control and resolve them.”

At this stage in the battle, it is well-known that the genetic jabs (they are not “vaccines”) developed by both Pfizer-BioNTech and Moderna pose numerous risks with their use, including post-jab thrombotic events, cardiovascular complications, as well as a wide variety of diseases involving all organs and systems, including the nervous system. It is also well-known that the Red Cross does not sort blood donors by COVID vaccination status. With those frightening facts in mind, it would be negligent to ignore that there are real and serious risks associated with blood transfusions coming from genetic vaccine recipients. This danger can’t be swept under the rug. The researchers’ article, titled “Concerns regarding Transfusions of Blood Products Derived from Genetic Vaccine Recipients and Proposals for Specific Measures,” aims to call medical professionals’ attention to the extensive risks associated with blood transfusions using blood products derived from people who received the mRNA jabs.

The seven researchers of the preprint, affiliated with Asahikawa Medical University, Tokyo Medical University Hospital, MCL Corporation, Kyoto, Okamura Memorial Hospital, Tokyo University of Science, and Kokoro Medical Corporation in Japan, assert that the risks associated with blood transfusions from individuals injected with the mRNA COVID-19 shots encompass a wide range of potential complications. With the frightening findings shared by embalmers working on the deceased corpses of those jabbed, it’s not surprising high on their list are blood abnormalities. The paper noted:

“Although it is unknown at present whether secondary damage is caused by transfusion of blood products derived from genetic vaccine recipients, it is necessary for medical institutions and administrative organizations to respond and investigate cooperatively, keeping various possibilities in mind, because the mechanisms such as the toxicity of the spike protein itself and the effects of the LNPs and modified mRNA on the immune response have not been fully elucidated and are still under study.

It should be emphasized that a significant proportion of the COVID-19 PVS (post-vaccination syndrome) in mRNA vaccine recipients is due to toxic spike proteins, and the inclusion of structures in the receptor-binding domain within these proteins that may induce prion disease is particularly alarming.”

Much appreciation to the researchers for highlighting that the effects of the LNPs (lipid nanoparticles, which invade the entire body) and modified mRNA on the immune response are “still under study.” That observation is undoubtedly an absolute, given the forced global clinical trial currently underway allowing the deep-state swindlers to tamper with toxic mRNA technology to one day include it in everything, including our food.

Another significant concern surrounding the use of blood from individuals injected with the mRNA COVID-19 jabs is immune dysfunction. Undoubtedly, gene-damaging jabs have the potential to lead to immune-related complications, including immune imprinting, antibody-dependent enhancement, and alterations in immunoglobulin class switching. These phenomena can influence the immune system’s response to subsequent infections, potentially increasing susceptibility to specific pathogens or autoimmune reactions. Significantly, with the spike protein still detectable in the bodies of injected people several months after getting the jab, the risk of immune imprinting is most likely higher than in conventional vaccines.

Neurological complications also make the checklist of conditions of grave concern with blood contaminated by the mRNA jabs. As pointed out by the researchers, “more people are complaining of psychiatric and neurological symptoms after genetic vaccination.” Why would the FDA stay silent on this when growing evidence suggests that the spike protein produced by mRNA jabs can cross the blood-brain barrier and has neurotoxic properties? Without question, this scary scenario highlights the need for thorough monitoring and assessment.

In what should be already occurring considering these identified risks, the researchers are calling for exhaustive testing protocols before blood donations, including screening for spike proteins, vaccine components, immune markers, and potential neurotoxicity indicators to identify any adverse effects. Indeed, clear regulatory guidelines must be established to govern how mRNA-tainted blood is collected, processed, stored, and transfused, with long-term monitoring and surveillance to track complications associated with using that blood. Without question, the researcher stated that public awareness about the risks of mRNA gene-damaging jabs, immune-related disorders, and blood transfusions must be created. Remarking on the convoluted situation the deadly mRNA jabs present to humanity and the skewed role of the World Health Organization (WHO) (as it seeks more power in future pandemics), the researchers stated:

“It is expected that the situation will already be complicated because, in contrast to previous drug disasters, genetic vaccination was implemented on a global scale and simultaneously for a substantial number of people. This means, as in the context of the coronavirus pandemic, or even more critically, that there is an urgent necessity for legislation and international treaties explicitly elucidating bilateral and multilateral agreements concerning the management of blood products. These legal frameworks should delineate regulations governing the handling of blood products and establish protocols for governmental compensation and response to issues and hazards associated with these products, including penalties and prohibitions. For example, the International Health Regulations (IHR) 2005 may be helpful, but given the WHO’s strong push for genetic vaccination, another framework may be needed.”